Baylor Genetics Neurodevelopmental Disorders Panel

Baylor Genetics has launched its Neurodevelopmental Disorders Panel for patients with suspected or clinically diagnosed autism spectrum disorder, intellectual disability, or developmental delay. The next-generation sequencing-based panel analyzes a set of 236 genes on an exome carvout and detects nucleotide variants, insertions and deletions, and copy number variants at "exceptional read depths," the laboratory said.